Viewing Study NCT04439266

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2026-01-31 @ 5:11 AM
Study NCT ID: NCT04439266
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2020-06-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Lymphoma View
None Advanced Malignant Solid Neoplasm View
None Hematopoietic and Lymphoid Cell Neoplasm View
None Refractory Lymphoma View
None Refractory Malignant Solid Neoplasm View
None Refractory Multiple Myeloma View
Keywords: